New Zealand provisionally approves use of Pfizer coronavirus vaccine

New Zealand's medicine regulator Medsafe has provisionally approved the use of the Pfizer COVID-19 vaccine. The vaccines are expected to arrive in New Zealand by the end of March, the Government said, adding that people at highest risk would be vaccinated before the broader community from the second half of the year. 'The provisional approval of the Pfizer-BioNTech vaccine is a positive step in New Zealand's fight against COVID-19,' Prime Minister Jacinda Ardern said.